43% of Parents with Children Under 5 Newly Eligible for a COVID-19 Vaccine Say They Will “Definitely Not” Get Them Vaccinated July 26, 2022 News Release Most Parents Open to Getting Their Young Child Vaccinated Haven’t Yet Spoken to Their Pediatrician Most parents of young children newly eligible for a COVID-19 vaccine are reluctant to get them vaccinated, including 43% who say they will “definitely not” do so, a new KFF COVID-19 Vaccine Monitor survey finds…
KFF COVID-19 Vaccine Monitor: July 2022 July 26, 2022 Poll Finding In the wake of the FDA’s emergency use authorization for COVID-19 vaccines for children ages 6 months through 4 years old, many parents remain hesitant to vaccinate their children in this age group, with a slight majority saying they view the vaccine as a bigger risk to their child’s health than getting infected with coronavirus.
COVID-19 Vaccination Rates Among Children Under 5 Have Peaked and Are Decreasing Just Weeks Into Their Eligibility July 22, 2022 Issue Brief Children between the ages of 6 months and 5 years of age finally became eligible for COVID-19 vaccination in the U.S. on June 18, after the Director of the Centers for Disease Control and Prevention (CDC) recommended their use for this population, following emergency use authorization granted by the Food and Drug Administration. Here, we examine the status of vaccine uptake in this group, one month into their eligibility.
Percent of Total Population that has Received a COVID-19 Vaccine by Race/Ethnicity July 15, 2022 State Indicator
Latest Data on COVID-19 Vaccinations by Race/Ethnicity July 14, 2022 Issue Brief KFF is collecting and analyzing data on COVID-19 vaccinations by race/ethnicity to gain increased insight who is receiving the vaccine and whether some groups are facing disparities in vaccination.
U.S. Global Funding for COVID-19 by Country and Region: An Analysis of USAID Data June 29, 2022 Issue Brief As Congress again considers increased assistance for the global response to COVID-19, we look at how current U.S. global COVID-19 emergency funding is being channeled, particularly to countries and regions.
How Equitable is Access to COVID-19 Treatments? June 23, 2022 Issue Brief This issue brief assesses the availability of oral antiviral treatments by county and certain county characteristics, including metro vs. non-metro status, poverty rate, and majority Black, Hispanic, or American Indian or Alaska Native (AIAN).
The Last Major Phase of the COVID-19 Vaccination Roll-out: Children Under 5 June 21, 2022 Issue Brief With the FDA authorization of both Moderna and Pfizer’s COVID-19 vaccine for children between the ages of 6 months and 5, the last major phase of the U.S. vaccination roll-out is underway. This brief provides an overview of the characteristics of children under the age of 5 and discusses some issues to consider in rolling out vaccination to this age group.
Immigrants in the U.S. Continue to Face Health Care Challenges June 16, 2022 Slide June marks National Immigrant Heritage Month, which honors the contributions of immigrants to the U.S. As of 2020, there were close to 45 million immigrants residing in the U.S., accounting for 14% of the total U.S. population. Immigrants make up a significant part of the nation’s workforce and families yet…